Clinical characteristics of a concurrent condition of IgG4-RD and Castleman’s disease

[1]  D. Shilling,et al.  Castleman Disease Pathogenesis. , 2018, Hematology/oncology clinics of North America.

[2]  T. Takeuchi,et al.  Distinct features distinguishing IgG4-related disease from multicentric Castleman’s disease , 2017, RMD Open.

[3]  Y. Kawabata,et al.  Comparison of clinical and pathological features of lung lesions of systemic IgG4‐related disease and idiopathic multicentric Castleman's disease , 2017, Histopathology.

[4]  T. Mimori,et al.  Current approach to the diagnosis of IgG4-related disease – Combination of comprehensive diagnostic and organ-specific criteria , 2017, Modern rheumatology.

[5]  S. Arai,et al.  Overlap of IgG4-related Disease and Multicentric Castleman's Disease in a Patient with Skin Lesions , 2017, Internal medicine.

[6]  K. Migita,et al.  Multicentric Castleman disease mimicking IgG4-related disease: A case report , 2017, Modern rheumatology.

[7]  Dermot Kelleher,et al.  Idiopathic multicentric Castleman's disease: a systematic literature review. , 2016, The Lancet. Haematology.

[8]  J. Zwerina,et al.  IgG4-related disease: current challenges and future prospects , 2016, Therapeutics and clinical risk management.

[9]  C. Cervantes,et al.  Castleman Disease: A Rare Condition with Endocrine Manifestations , 2015, Cureus.

[10]  K. Okazaki,et al.  Comprehensive Diagnostic Criteria for IgG4-Related Disease , 2014 .

[11]  H. Mukae,et al.  Assessment of Pathologically Diagnosed Patients with Castleman’s Disease associated with Diffuse Parenchymal Lung Involvement Using the Diagnostic Criteria for IgG4-Related Disease , 2013, Lung.

[12]  K. Takata,et al.  Cutaneous multicentric Castleman's disease mimicking IgG4-related disease. , 2012, Pathology, research and practice.

[13]  J. Stone,et al.  Development of an IgG4-RD Responder Index , 2012, International journal of rheumatology.

[14]  T. Hibi,et al.  Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 , 2012, Modern rheumatology.

[15]  T. Hibi,et al.  Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 , 2012, Modern rheumatology.

[16]  Y. Jeon,et al.  Comparison of Plasma Cell Type of Castleman’s Disease and IgG4-Related Sclerosing Disease: A Histopathological and Immunohistochemical Study , 2011, Pathobiology.

[17]  Daisuke Kobayashi,et al.  A case of IgG4-related disease with features of Mikulicz’s disease, and retroperitoneal fibrosis and lymphadenopathy mimicking Castleman’s disease , 2011, Modern rheumatology.

[18]  K. Takata,et al.  Multicentric Castleman's disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases , 2010, Journal of Clinical Pathology.

[19]  M. Papathanasiou,et al.  Orbital involvement in Castleman disease. , 2010, Survey of ophthalmology.

[20]  M. Kojima,et al.  Castleman's disease of the retroperitoneum: with special reference to IgG4-related disorder. , 2010, Journal of clinical and experimental hematopathology : JCEH.

[21]  H. Asaoku,et al.  Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease , 2009, Modern Pathology.

[22]  M. Kageoka,et al.  [Retroperitoneal fibrosis and Castleman disease in two patients with high IgG4 levels]. , 2008, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[23]  J. Bousquet,et al.  A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. , 2001 .

[24]  J. Bousquet,et al.  A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task force , 2001, Allergy.

[25]  F. Ishida,et al.  Elevated IgG4 levels in a case with multicentric Castleman's disease. , 1997, British journal of haematology.

[26]  D. C. Henckel,et al.  Case report. , 1995, Journal.